Literature DB >> 30633597

Blood coagulation: a powerful bactericidal mechanism of human innate immunity.

Hayk Minasyan1, Friedrich Flachsbart2.   

Abstract

Infection proliferates and disseminates rapidly and so innate immunity should react effectively and fast. Innate immunity mechanisms depend upon fluid dynamics and are different in compartments with slow (the tissues) and rapid (the bloodstream) liquid flow. In the tissues, coagulation initiated by clotting factors, platelets and erythrocytes, is prompt and effective mechanism of the first line of antibacterial defense. Resident macrophages, transmigrated neutrophils, monocytes, NETs and platelets are the second line of the defense. In the bloodstream the first line of innate immunity defense are erythrocytes that kill pathogens by oxygen, released from oxyhemoglobin (oxycytosis); the second line of the defense is coagulation that in case of overactivation may cause disseminated intravascular coagulation (DIC). Blood coagulation is the fastest mechanism of infection confinement and inactivation. It is the first and the last line of innate immunity defense and occurs both in the tissues and the bloodstream.

Entities:  

Keywords:  Coagulation; erythrocytes; innate immunity; leukocytes; platelets

Year:  2019        PMID: 30633597     DOI: 10.1080/08830185.2018.1533009

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  9 in total

1.  Evaluation of Blood Coagulation by Optical Vortex Tracking.

Authors:  Jiaxing Gong; Yaowen Zhang; Hui Zhang; Qi Li; Guangbin Ren; Wenjian Lu; Jing Wang
Journal:  Sensors (Basel)       Date:  2022-06-24       Impact factor: 3.847

Review 2.  Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection.

Authors:  Poojith Nuthalapati; Mohan Krishna Ghanta; Nagabhishek Sirpu Natesh; Bhaskar L V K S
Journal:  Blood Res       Date:  2021-06-30

Review 3.  Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature.

Authors:  Matheus Pelinski da Silveira; Kimberly Kamila da Silva Fagundes; Matheus Ribeiro Bizuti; Édina Starck; Renata Calciolari Rossi; Débora Tavares de Resende E Silva
Journal:  Clin Exp Med       Date:  2020-07-29       Impact factor: 3.984

4.  Dysfunctional Coagulation in COVID-19: From Cell to Bedside.

Authors:  Jie Wang; Ardan M Saguner; Jiaqi An; Yuye Ning; Yang Yan; Guoliang Li
Journal:  Adv Ther       Date:  2020-06-05       Impact factor: 3.845

5.  Coagulopathy in elderly patients with coronavirus disease 2019.

Authors:  Xueting Yuan; Xunliang Tong; Yan Wang; He Wang; Liuming Wang; Xiaomao Xu
Journal:  Aging Med (Milton)       Date:  2020-12-29

6.  Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19.

Authors:  Rongrong Ding; Zongguo Yang; Dan Huang; Yanbing Wang; Xiufen Li; Xinlan Zhou; Li Yan; Wei Lu; Zhanqing Zhang
Journal:  Int J Med Sci       Date:  2021-01-14       Impact factor: 3.738

7.  Patterns of organizing pneumonia and microinfarcts as surrogate for endothelial disruption and microangiopathic thromboembolic events in patients with coronavirus disease 2019.

Authors:  Katharina Martini; Christian Blüthgen; Joan Elias Walter; Thi Dan Linh Nguyen-Kim; Friedrich Thienemann; Thomas Frauenfelder
Journal:  PLoS One       Date:  2020-10-05       Impact factor: 3.240

8.  Thrombus in Transit on Point-of-Care Ultrasound in COVID-19 Pneumonia: A Cause of Refractory Hypoxia Requiring Systemic Thrombolysis.

Authors:  Neema Jayachamarajapura Onkarmurthy; Ibrahim Omore; Michelle Thomas; Farbod Raiszadeh
Journal:  Cureus       Date:  2021-06-11

Review 9.  Rational selection of bioactive principles for wound healing applications: Growth factors and antioxidants.

Authors:  Pamela Viaña-Mendieta; Mirna Lorena Sánchez; Jorge Benavides
Journal:  Int Wound J       Date:  2021-05-05       Impact factor: 3.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.